Transforming the Small Molecule to Medicine Product Design Process?

3/12/2018 08:30 - 09:10



  • Increasing small molecule complexity and accelerated regulatory filings timings are leading us to rethink our drug delivery and development strategy
  • Computational and predictive sciences will transform all aspects of accelerated drug product development
  • A focus on continuous manufacturing will revolutionise our approach to scale up and variable commercial batch sizes.
  • Developing a talent blueprint for our workforce will be key to our exciting future in drug development

Brian Henry, Vice President Drug Product Design, Pfizer